Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (33)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Herrero, I.
Right arrow Articles by Grinyo, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herrero, I.
Right arrow Articles by Grinyo, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrology Dialysis Transplantation, Vol 14, Issue 4 872-880, Copyright © 1999 by Oxford University Press

ORIGINAL ARTICLES

Prevention of cold ischaemia-reperfusion injury by an endothelin receptor antagonist in experimental renal transplantation

I Herrero, J Torras, M Riera, E Condom, O Coll, J Cruzado, M Hueso, J Bover, N Lloberas, J Alsina and J Grinyo
Laboratory of Nephrology, Department of Medicine, University of Barcelona, Nephrology Service and Pathology Service, Hospital of Bellvitge, Ciutat Sanitaria i Universitaria de Bellvitge, Feixa Llarga s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain; Corresponding author

Background. Endothelin (ET) is known to play a role in the pathogenesis of warm ischaemic renal damage, however, little is known about its involvement in renal cold ischaemia. This study was designed to investigate the response of ET after kidney cold ischaemia, and to assess the potential protective effect of bosentan, a dual, non-selective ETA/ETB receptor antagonist, against cold ischaemia-reperfusion injury in a rat model of syngeneic renal transplantation. Methods. Kidneys from Lewis rats were transplanted, either immediately or after 5 h of cold preservation. After 48 h, contralateral nephrectomy was performed. Rats were organized into three groups: Tr-NoISC, no cold ischaemia; Tr-ISC, 5 h cold ischaemia; and Tr-BOS, 5 h cold ischaemia plus bosentan (100 mg/kg/day, from the day before transplantation until the seventh day post-transplantation). On day 7, plasma and tissue immunoreactive ET (irET), as well as ET mRNA tissue expression, were evaluated. Renal function was measured by means of serum creatinine on day 7. Conventional histology was performed. Results. The ischaemic group had significantly higher plasma irET levels than the non-ischaemic group and significantly lower levels than the bosentan group. Tissue irET levels and ET mRNA expression were higher than in the non-ischaemic group. Throughout the follow-up, serum creatinine was significantly higher in the ischaemic group than in the bosentan group. Moreover, creatinine decreased rapidly in the bosentan group after nephrectomy, whereas it continued to increase for 48 h in the ischaemic group. Kidneys from the ischaemic group showed a higher degree of tubular-cell necrosis and epithelial-cell detachment than kidneys from the bosentan group. Conclusions. We conclude that cold ischaemia and preservation damage induces an increase in renal ET mRNA and irET expression in the reperfusion phase, contributing both to the deterioration of renal function and to tubular necrosis. Bosentan is effective in protecting kidneys from this cold ischaemia-reperfusion damage. Non-selective ETA/ETB receptor antagonists might be potentially useful in clinical renal transplantation. Keywords: cold ischaemia-reperfusion injury; endothelin; ETA/ETB receptor antagonist; rat renal transplantation
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
M. Jerkic, Z. Miloradovic, D. Jovovic, N. Mihailovic-Stanojevic, J. V. R. Elena, D. Nastic-Miric, G. Grujic-Adanja, A. Rodriguez-Barbero, J. Markovic-Lipkovski, S. B. Vojvodic, et al.
Relative roles of endothelin-1 and angiotensin II in experimental post-ischaemic acute renal failure
Nephrol. Dial. Transplant., January 1, 2004; 19(1): 83 - 94.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
I. Herrero-Fresneda, J. Torras, J. M. Cruzado, E. Condom, A. Vidal, M. Riera, N. Lloberas, J. Alsina, and J. M. Grinyo
Do Alloreactivity and Prolonged Cold Ischemia Cause Different Elementary Lesions in Chronic Allograft Nephropathy?
Am. J. Pathol., January 1, 2003; 162(1): 127 - 137.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
A. Kato and A. Hishida
Amelioration of post-ischaemic renal injury by contralateral uninephrectomy: a role of endothelin-1
Nephrol. Dial. Transplant., August 1, 2001; 16(8): 1570 - 1576.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
J. M. Cruzado, J. Torras, M. Riera, I. Herrero, M. Hueso, L. Espinosa, E. Condom, N. Lloberas, J. Bover, J. Alsina, et al.
Influence of nephron mass in development of chronic renal failure after prolonged warm renal ischemia
Am J Physiol Renal Physiol, August 1, 2000; 279(2): F259 - F269.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.